Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)

Exclusion Criteria

• •Unable or unwilling to provide signed, Informed Consent
• •Less than 1 year of age
• •SARS-Cov-2 RT-PCR collection that occurred \> 3 hours from CoviDx Rapid Antigen Swab collection
• •First onset of COVID-19-like symptoms occurring more than 5 days from study visit
• •Invalid or missing PCR test results
• •Use of a non-high-sensitive SARS-CoV-2 test as the qualifying SARS-CoV-2 RT-PCR test (e.g., Abbott ID NOW, rapid antigen tests, tests that do not have FDA EUA, a test that was not approved by Sponsor for use in the study)
• •Enrollment in another study involving the collection of a nasopharyngeal or nasal swab
• •Receipt of a COVID-19 vaccine or participation in a COVID-19 vaccine study